Logos Global Management LP Blueprint Medicines Corp Transaction History
Logos Global Management LP
- $761 Million
- Q4 2024
A detailed history of Logos Global Management LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Logos Global Management LP holds 200,000 shares of BPMC stock, worth $16.5 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$16.5 Million% of portfolio
2.29%Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$559 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$549 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$469 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$206 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$160 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $4.93B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...